APA
Yamazaki K., Shimizu M., Okuno M., Matsushima-Nishiwaki R., Kanemura N., Araki H., Tsurumi H., Kojima S., Weinstein I. B. & Moriwaki H. (20071120). Synergistic effects of RXR alpha and PPAR gamma ligands to inhibit growth in human colon cancer cells--phosphorylated RXR alpha is a critical target for colon cancer management. : Gut.
Chicago
Yamazaki Kenji, Shimizu Masahito, Okuno Masataka, Matsushima-Nishiwaki Rie, Kanemura Nobuhiro, Araki Hiroshi, Tsurumi Hisashi, Kojima Soichi, Weinstein I Bernard and Moriwaki Hisataka. 20071120. Synergistic effects of RXR alpha and PPAR gamma ligands to inhibit growth in human colon cancer cells--phosphorylated RXR alpha is a critical target for colon cancer management. : Gut.
Harvard
Yamazaki K., Shimizu M., Okuno M., Matsushima-Nishiwaki R., Kanemura N., Araki H., Tsurumi H., Kojima S., Weinstein I. B. and Moriwaki H. (20071120). Synergistic effects of RXR alpha and PPAR gamma ligands to inhibit growth in human colon cancer cells--phosphorylated RXR alpha is a critical target for colon cancer management. : Gut.
MLA
Yamazaki Kenji, Shimizu Masahito, Okuno Masataka, Matsushima-Nishiwaki Rie, Kanemura Nobuhiro, Araki Hiroshi, Tsurumi Hisashi, Kojima Soichi, Weinstein I Bernard and Moriwaki Hisataka. Synergistic effects of RXR alpha and PPAR gamma ligands to inhibit growth in human colon cancer cells--phosphorylated RXR alpha is a critical target for colon cancer management. : Gut. 20071120.